Gregory Eschenauer , clinical associate professor at the University of Michigan College of Pharmacy, has been appointed to the NIH COVID-19 Treatment Guideline Panel, convened by Dr. Anthony Fauci.
The panel is composed of academicians, clinicians and representatives from multiple professional societies and government agencies to provide current, evidence-based care recommendations for COVID-19 patients. It was convened by Fauci, director of the National Institute of Allergy and Infectious Diseases, in March 2020.
Eschenauer, also a clinical pharmacy specialist in infectious diseases at Michigan Medicine, is an expert in infectious disease and antimicrobial stewardship. He represents the Society of Infectious Diseases Pharmacists on the panel. His role is to review new literature pertaining to COVID-19 therapeutics, assist in the writing and development of updates, and participate in discussions regarding such changes.
Eschenauer completed his pharmacy practice and infectious diseases specialty residencies at U-M and is a member of the Michigan Medicine Antimicrobial Stewardship Program, a multidisciplinary team that works to ensure effective and appropriate utilization of antimicrobials for hospitalized patients, reevaluate treatments of common infections and set best practices.
The program is responsible for developing and maintaining institutional COVID-19 therapeutic guidelines within Michigan Medicine. During the height of the pandemic, it also performed observational research to inform their local practice while awaiting the results of clinical trials.
Eschenauer joins fellow Michigan Pharmacy alumna Alice Pau on the panel and replaces another U-M College of Pharmacy alumna, Susan Davis, who stepped down in consideration of her new administrative role at Wayne State University.
412 Maynard St.